Contraception, pregnancy and MAVENCLAD®

Contraception, pregnancy and MAVENCLAD®

Hello again,

We will be discussing contraception and pregnancy while on MAVENCLAD.

If you have any questions after watching, please talk to your healthcare professional, or call the adveva team.

Whether you’re a man or a woman, there are a few things you need to know while you are using MAVENCLAD.

Firstly, both men and women must use effective contraception during treatment with MAVENCLAD and not stop using it for at least 6 months after the final dose.

For female patients, it’s not known if MAVENCLAD reduces the effectiveness of birth control pills. Given this, a barrier method of contraception (for example, condoms) should be added to the birth control pill during treatment with MAVENCLAD and for at least 4 weeks after the last dose in each treatment year.

Please discuss the most appropriate methods of contraception for you and your partner with your healthcare professional.

Let your healthcare professional know if you think you are pregnant before taking MAVENCLAD in years 1 and 2.

You should contact your healthcare professional as soon as possible if you or your partner becomes pregnant. Women who become pregnant while taking MAVENCLAD should stop treatment.

Your healthcare professional will give you guidance on how your pregnancy will be monitored and might ask if your details can be collected in a special database called a pregnancy registry.

It is not known if MAVENCLAD affects male fertility. If you would like advice about this, please talk to your doctor or your multiple sclerosis nurse.

As always, if you would like to talk to someone about MAVENCLAD, we’re here to help, at 1-888-677-3243.

Thanks and see you soon.




Get important details about MAVENCLAD and pregnancy®





Print and complete this wallet card and keep it handy for your healthcare team or in case of emergency






MAVENCLAD is a trademark of Merck KGaA, Darmstadt, Germany or its affiliates.










Leaving site

You’ve clicked on an external link and are about to leave the adveva site.